OsteopetrosisPathogenesis and Rationale for the Use of Interferon-γ-1b

被引:0
|
作者
Lakshmi Shankar
Egbert J. A. Gerritsen
L. Lyndon Key
机构
[1] Medical University of South Carolina,Department of Pediatrics and General Clinical Research Center
[2] Hospital for Sick Children NHS Trust and Institute of Child Health,Department of Immunology
来源
BioDrugs | 1997年 / 7卷
关键词
Bone Resorption; Chronic Granulomatous Disease; Osteopetrosis; Osteoclastic Bone Resorption; Dietary Calcium Intake;
D O I
暂无
中图分类号
学科分类号
摘要
Congenital osteopetrosis is a group of disorders resulting in decreased osteoclastic function and hence decreased bone resorption. Various medical treatments have been attempted to ameliorate the osteopetrotic condition. A calcium-deficient diet has limited further sclerosis in some patients. Prednisone therapy has improved haematological function in some patients, but has not resulted in a reduction in bone mass. Calcitrophic hormones, such as parathyroid hormone (PTH) infusions and oral calcitriol, stimulate osteoclastic activity, and calcitriol in particular has stimulated osteoclastic bone resorption in some patients with osteopetrosis. Bone marrow transplantation, although curative, is limited by paucity of donors, risk of graft-versus-host disease and relapse of the disease.
引用
收藏
页码:23 / 29
页数:6
相关论文
共 50 条
  • [31] Interferon-β-1b -: A review of its use in relapsing-remitting and secondary progressive multiple sclerosis
    McCormack, PL
    Scott, LJ
    CNS DRUGS, 2004, 18 (08) : 521 - 546
  • [32] Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro
    Danrong Shi
    Keda Chen
    Xiangyun Lu
    Linfang Cheng
    Tianhao Weng
    Fumin Liu
    Nanping Wu
    Lanjuan Li
    Hangping Yao
    Virologica Sinica, 2022, 37 (02) : 295 - 298
  • [33] Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro
    Danrong Shi
    Keda Chen
    Xiangyun Lu
    Linfang Cheng
    Tianhao Weng
    Fumin Liu
    Nanping Wu
    Lanjuan Li
    Hangping Yao
    Virologica Sinica, 2022, (02) : 295 - 298
  • [34] Recombinant human interferon-?1b inhibits SARS-CoV-2 better than interferon-?2b in vitro
    Shi, Danrong
    Chen, Keda
    Lu, Xiangyun
    Cheng, Linfang
    Weng, Tianhao
    Liu, Fumin
    Wu, Nanping
    Li, Lanjuan
    Yao, Hangping
    VIROLOGICA SINICA, 2022, 37 (02) : 295 - 298
  • [35] Combined treatment of multiple sclerosis patients with cytostatics and interferon-β (1a,1b)
    Daskalovska, V
    Dimova, A
    Bojkovski, V
    Boskova-Petkovska, T
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S262
  • [36] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [37] Recombinant Human Interferon-β-1a (Rebif®) vs Recombinant Interferon-β-1b (Betaseron®) in Healthy VolunteersA Pharmacodynamic and Tolerability Study
    M. Buraglio
    I. Trinchard-Lugan
    A. Munafo
    M. Macnamee
    Clinical Drug Investigation, 1999, 18 : 27 - 34
  • [38] Recombinant human interferon-β-1a (Rebif®) vs recombinant interferon-β-1b (Betaseron®) in healthy volunteers -: A pharmacodynamic and tolerability study
    Buraglio, M
    Trinchard-Lugan, I
    Munafo, A
    Macnamee, M
    CLINICAL DRUG INVESTIGATION, 1999, 18 (01) : 27 - 34
  • [39] Interferon-β1b Increases Th2 Response in Neuromyelitis Optica
    Nakajima, Hideto
    Hosokawa, Takafumi
    Doi, Yoshimitu
    Ikemoto, Toshiyuki
    Ishida, Shimon
    Kimura, Fumiharu
    Hanafusa, Toshiaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (10) : 12213 - 12223
  • [40] Site Directed Disulfide PEGylation of Interferon-β-1b with Fork Peptide Linker
    Abbasi, Shayan
    Farahani, Homa
    Lanjanian, Hossein
    Taheri, Mohammad
    Firoozpour, Loghman
    Davoodi, Jamshid
    Pirkalkhoran, Sama
    Riazi, GholamHossein
    Pooyan, Shahriar
    BIOCONJUGATE CHEMISTRY, 2020, 31 (03) : 708 - 720